rbarb, their PR sounds much better than ours. Ours should have said the same "We have met our first milestone of designing 25 peptide vaccine combinations for testing and are awaiting payment from the $1M expense allowance".
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.